Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up

被引:21
|
作者
Hajili, Turkan [1 ]
Ohlmann, Carsten H. [1 ]
Linxweiler, Johannes [1 ]
Niklas, Christina [1 ]
Janssen, Martin [1 ]
Siemer, Stefan [1 ]
Stoeckle, Michael [1 ]
Saar, Matthias [1 ]
机构
[1] Saarland Univ, Dept Urol & Pediat Urol, D-66421 Homburg, Germany
关键词
inductive androgen deprivation; inoperable high-risk prostate cancer; prostate-specific antigen nadir; radical prostatectomy; #pcsm; #ProstateCancer; NEOADJUVANT HORMONAL-THERAPY; HIGH-RISK; PHASE-II; MEN; SURVIVAL; ADENOCARCINOMA;
D O I
10.1111/bju.14393
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo determine the outcomes of complete surgical resection of T4 prostate cancer after inductive androgen-deprivation therapy (ADT), as inductive ADT and subsequent radical prostatectomy (RP) is not recommended by any guideline yet. Patients and MethodsA monocentric RP database was queried for patients initially diagnosed with T4 prostate cancer, considered primarily as inoperable because of a fixed mass defined by rectal examination in combination with high PSA level and/or large foci of biopsy confirmed undifferentiated prostate cancer. Treatment consisted of primary ADT until PSA nadir with consecutive RP. Patients underwent retropubic RP (RRP) or robot-assisted laparoscopic RP (RALP) after inductive ADT until achievement of the PSA nadir, which is in general reached after 6-7months. The intraoperative course and complications were analysed. Finally, Kaplan-Meier estimates were calculated for overall survival (OS) and prostate cancer-specific survival (PCSS). ResultsWe retrospectively identified 116 patients treated between 2000 and 2014. At diagnosis, the median (range) PSA level was 37.6 (2.44-284) ng/mL. The preoperative median (range) PSA after inductive ADT was 0.73 (0.01-34) ng/mL. Thereafter, patients underwent RRP or, since 2006, RALP. The median (95% confidence interval) OS was 156 (118.9-193.1) months. The PCSS at 150months was 82%. ConclusionsSurgical therapy of primarily inoperable prostate cancer is feasible and safe after inductive ADT. The OS of this cohort seems comparable with results described for patients with primary operable high-risk prostate cancer.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 50 条
  • [21] Long-Term Oncologic Results and Complications After Preoperative Chemoradiotherapy for Rectal Cancer: A Single-Institution Experience After a Median Follow-Up of 95 Months
    Salvatore Pucciarelli
    Giuseppe Gagliardi
    Isacco Maretto
    Sara Lonardi
    Maria Luisa Friso
    Emanuele Urso
    Paola Toppan
    Donato Nitti
    Annals of Surgical Oncology, 2009, 16
  • [22] 'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases
    Bostwick, DG
    Bostwick, KC
    BJU INTERNATIONAL, 2004, 94 (01) : 57 - 58
  • [23] Comparative effectiveness of radical prostatectomy and curative radiotherapy in localized prostate cancer: long-term follow-up
    Tamada, Satoshi
    Ninomiya, Noriko
    Kitamoto, Koichiro
    Kato, Minoru
    Yamasaki, Takeshi
    Iguchi, Taro
    Ohmachi, Tetsuji
    Nakatani, Tatsuya
    JOURNAL OF RADIATION RESEARCH, 2017, 58 (04) : 552 - 558
  • [24] Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
    Lundar, Tryggve
    Due-Tonnessen, Bernt Johan
    Fric, Radek
    Egge, Arild
    Krossnes, Bard
    Due-Tonnessen, Paulina
    Stensvold, Einar
    Brandal, Petter
    ACTA NEUROCHIRURGICA, 2018, 160 (06) : 1207 - 1214
  • [25] Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
    Tryggve Lundar
    Bernt Johan Due-Tønnessen
    Radek Fric
    Arild Egge
    Bård Krossnes
    Paulina Due-Tønnessen
    Einar Stensvold
    Petter Brandal
    Acta Neurochirurgica, 2018, 160 : 1207 - 1214
  • [26] Long term follow-up of stages T2-T3 prostate cancer pretreated with androgen ablation therapy prior to radical prostatectomy
    Lee, F
    Siders, DB
    McHug, TA
    Solomon, MH
    Klamerus, ML
    ANTICANCER RESEARCH, 1997, 17 (3A) : 1507 - 1510
  • [27] LONG-TERM FOLLOW-UP AFTER RADICAL PROSTATECTOMY - IDENTIFICATION OF PROGNOSTIC VARIABLES
    SMITH, JA
    HERNANDEZ, AD
    WITTWER, CJ
    AVENT, JM
    GREENWOOD, J
    HAMMOND, EH
    MIDDLETON, RG
    UROLOGIC CLINICS OF NORTH AMERICA, 1991, 18 (03) : 473 - 476
  • [28] TESTOSTERONE REPLACEMENT THERAPY AFTER RADICAL PROSTATECTOMY: LONG-TERM FOLLOW-UP
    Pastuszak, Alexander W.
    Pearlman, Amy
    Sathyamoorthy, Kumaran
    Lipshultz, Larry I.
    Khera, Mohit
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 15 - 16
  • [29] Need for long-term follow-up in sinonasal inverted papilloma: A Single-institution experience
    Binz, Gregori H. A.
    Soyka, Michael B.
    Holzmann, David
    Meerwein, Christian M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (02): : 630 - 638
  • [30] Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer
    D'Amico, Anthony V.
    Chen, Ming-Hui
    Renshaw, Andrew
    Loffredo, Marian
    Kantoff, Philip W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (12): : 1291 - 1293